Utku Erdem Soyaltin

Utku Erdem Soyaltin

Auto-generated profile, based on publicly available information

Utku Erdem Soyaltin

Department of Internal Medicine, Division of Endocrinology and Metabolism Disorders, Faculty of Medicine, Ege University, Izmir, Turkey

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
ISILGIN YILDIRIM SIMSIR
ILGIN YILDIRIM SIMSIR
USUtku Erdem Soyaltin
Utku Erdem Soyaltin
SCSevki Cetinkalp
Sevki Cetinkalp

11 April 2023 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Open access
ISILGIN YILDIRIM SIMSIR
ILGIN YILDIRIM SIMSIR
BTBeyhan Tüysüz
Beyhan Tüysüz
MOMehmet Nuri Ozbek
Mehmet Nuri Ozbek
STSeher Tanrikulu
Seher Tanrikulu
MGMerve Celik Guler
Merve Celik Guler
BABaris Akinci
Baris Akinci
Aim: To describe the Turkish generalized lipodystrophy (GL) cohort with the frequency of each complication and the death rate during the period of the follow‐up. Methods: This study reports on 72 patients with GL (47 families) registered at different centres in Turkey that cover all regions of the country. The mean ± SD follow‐up was 86 ± 78 months. Results: The Kaplan–Meier estimate of the median time to diagnosis of diabetes and/or prediabetes was 16 years. Hyperglycaemia was not controlled in 37 of 45 patients (82.2%) with diabetes. Hypertriglyceridaemia developed in 65 patients (90.3%). The Kaplan–Meier estimate of the median time to diagnosis of hypertriglyceridaemia was 14 years. Hypertriglyceridaemia was severe (≥ 500 mg/dl) in 38 patients (52.8%). Seven (9.7%) patients suffered from pancreatitis. The Kaplan–Meier estimate of the median time to diagnosis of hepatic steatosis was 15 years. Liver disease progressed to cirrhosis in nine patients (12.5%). Liver disease was more severe in congenital lipodystrophy type 2 (CGL2). Proteinuric chronic kidney disease (CKD) developed in 32 patients (44.4%) and cardiac disease in 23 patients (31.9%). Kaplan–Meier estimates of the median time to diagnosis of CKD and cardiac disease were 25 and 45 years, respectively. Females appeared to have a more severe metabolic disease, with an earlier onset of metabolic abnormalities. Ten patients died during the follow‐up period. Causes of death were end‐stage renal disease, sepsis (because of recurrent intestinal perforations, coronavirus disease, diabetic foot infection and following coronary artery bypass graft surgery), myocardial infarction, heart failure because of dilated cardiomyopathy, stroke, liver complications and angiosarcoma. Conclusions: Standard treatment approaches have only a limited impact and do not prevent the development of severe metabolic abnormalities and early onset of organ complications in GL.

13 March 2019 in Endocrine
Verified
Journal Article
Closed access
PDF file
ISILGIN YILDIRIM SIMSIR
ILGIN YILDIRIM SIMSIR
USUtku Erdem Soyaltin
Utku Erdem Soyaltin
GOGokhan Osman Ozgen
Gokhan Osman Ozgen

18 June 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
ISILGIN YILDIRIM SIMSIR
ILGIN YILDIRIM SIMSIR
USUtku Erdem Soyaltin
Utku Erdem Soyaltin
BYBanu Pinar Sarer Yurekli
Banu Pinar Sarer Yurekli
MEMehmet Erdoğan
Mehmet Erdoğan
SCSevki Cetinkalp
Sevki Cetinkalp
GOGokhan Osman Ozgen
Gokhan Osman Ozgen
High triglyceride (TG) levels are associated with increases in atherosclerotic cardiovascular disease (CVD), hepatic steatosis, and pancreatitis. Acute pancreatitis is a condition with high mortality. Therapeutic plasma exchange (TPE) in the treatment of hypertriglyceridemic pancreatitis (HTGP) is a rapid and effective treatment modality. In this study, the results of TPE were evaluated and the frequency of lipoprotein lipase (LPL) mutation in these patients was determined. TPE was performed in 31 patients with HTGP at the Adult Therapeutic Apheresis Center. A TG level under 500 mg/dL was achieved by applying apheresis at a median of 2 times (IQR 2–2, min 1, max 6) in the 31 cases. LPL mutation was detected in 8 (25.8%) of the 31 hypertriglyceridemia cases. When TG levels before and after TPE were evaluated, the mean TG level before TPE was significantly higher (3132 ± 1472 mg/dL) than the mean TG level afterwards (948 ± 465 mg/dL, P < 0.001). This result represented a decrease of 69.7% TG after TPE. TPE is a safe, fast, and effective treatment modality in experienced centers.


8 November 2022 in Hormones
Verified
Journal Article
Closed access
PDF file
EKEsma Pehlivan Koroglu
Esma Pehlivan Koroglu
USUtku Erdem Soyaltin
Utku Erdem Soyaltin
SYSena Yeral
Sena Yeral
BYBanu Pinar Sarer Yurekli
Banu Pinar Sarer Yurekli